logo

For the Inventor, By the Inventor

Tokushima, Japan

Junichi Kawasaki

This inventor holds 15 USPTO granted patents and 4 published patent applications and 7 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Otsuka Pharmaceutical Company, Limited, Ostuka Pharmaceutical Co., Ltd.. Active years: 2007-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junichi Kawasaki. Retrieved from https://idiyas.com/inventor/junichi-kawasaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 53.3

 

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 116(Granted Patents)


Location History:

  • Tokushima-ken, JP (2007)
  • Itano-gun, JP (2014)
  • Osaka, JP (2017)
  • Tokushima, JP (2011 - 2018)

Company Filing History:

goldMedal14 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents
silverMedal1 out of 2 
 
Ostuka Pharmaceutical Co., Ltd.
 patents

Years Active: 2007-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Aripiprazole
Cilostazol
Solid Dispersion
Pharmaceutical Composition
Helicobacter Pylori
Drug Preparation
Low Hygroscopicity
2,3-Dihydro-6-Nitroimidazo
15 patents (USPTO):Explore Patents
1. 10150735 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2018-12-11),
2. 9555026 - Solid dispersion comprising amorphous cilostazol (2017-01-31),
3. 9359302 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2016-06-07),
4. 8993761 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2015-03-31),
5. 8901303 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2014-12-02),
6. 8901130 - Low hygroscopic aripiprazole drug substance and processes for the preparation (2014-12-02),
7. 8703773 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2014-04-22),
8. 8703772 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2014-04-22),
9. 8642760 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2014-02-04),
10. 8580796 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2013-11-12),
11. 8399469 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2013-03-19),
12. 8017615 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2011-09-13),
13. 7943623 - Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo [2,1-B] oxazole derivatives (2011-05-17),
14. 7910589 - Low hygroscopic aripiprazole drug substance and processes for the preparation thereof (2011-03-22),
15. 7201891 - Pharmaceutical preparation for the diagnosis of helicobacter pylori infection (2007-04-10),

Title: **Junichi Kawasaki: Pioneering Innovations in Pharmaceutical Development**

Introduction

Junichi Kawasaki, an accomplished inventor based in Tokushima, Japan, has made significant contributions to the field of pharmaceuticals. With a portfolio of 15 patents, his work focuses on developing innovative drug substances and formulations that enhance therapeutic efficacy.

Latest Patents

Among Junichi Kawasaki's latest inventions are two notable patents. The first, titled "Low Hygroscopic Aripiprazole Drug Substance and Processes for the Preparation Thereof," addresses the challenge of hygroscopicity in pharmaceuticals. This invention presents low hygroscopic forms of aripiprazole that maintain their solubility and do not convert to hydrates even with prolonged storage. The second patent, "Solid Dispersion Comprising Amorphous Cilostazol," pertains to a formulation that utilizes methacrylic acid copolymers to retain cilostazol in an amorphous state within the gastrointestinal tract, potentially improving its absorption following oral administration.

Career Highlights

Kawasaki's career includes valuable experience at Otsuka Pharmaceutical Company, Limited, and Otsuka Pharmaceutical Co. Ltd. His expertise in drug formulation has played a crucial role in advancing the company's product offerings and enhancing patient outcomes.

Collaborations

Throughout his career, Junichi Kawasaki has collaborated with esteemed colleagues such as Takuji Bando and Satoshi Aoki. These partnerships have fostered an environment of innovation and creativity, allowing for the successful development of new pharmaceutical solutions.

Conclusion

Junichi Kawasaki's contributions to pharmaceutical inventions underscore the importance of research and development in enhancing medication performance. His patents reflect a commitment to creating more effective therapeutic options, ultimately benefiting patients and healthcare providers alike. As the pharmaceutical landscape continues to evolve, inventors like Kawasaki will remain at the forefront of innovation, driving advancements that shape the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…